- $2.12bn
- $2.87bn
- $694.71m
- 83
- 38
- 73
- 69
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 487 | 511 | 590 | 618 | 695 |
Cost of Revenue | |||||
Gross Profit | 274 | 284 | 340 | 330 | 358 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 343 | 369 | 393 | 325 | 559 |
Operating Profit | 145 | 141 | 197 | 293 | 136 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 117 | 124 | 182 | 268 | 85.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 104 | 105 | 161 | 239 | 79.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 103 | 104 | 161 | 239 | 79.7 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 103 | 104 | 161 | 239 | 79.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.41 | 1.43 | 2.24 | 1.93 | 1.97 |
Dividends per Share |